Zimmer Biomet Holdings, Inc. (ZBH) - Comprehensive Stock Analysis & Investment Research
Deep dive into Zimmer Biomet Holdings, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Zimmer Biomet Holdings, Inc. Investment Summary
When evaluating whether Zimmer Biomet Holdings, Inc. (ZBH) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Zimmer Biomet Holdings, Inc. (ZBH) operates within the Industrial Applications and Services sector, specifically in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry. The company employs approximately 16,972 people. With a market capitalization of $18 billion, the company is a large-cap stock offering relative stability combined with growth potential.
Financial Performance Analysis
Our comprehensive financial analysis covers Zimmer Biomet Holdings, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Zimmer Biomet Holdings, Inc. along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Zimmer Biomet Holdings, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Zimmer Biomet Holdings, Inc. (Stock Symbol: ZBH) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry. The company's shares are publicly traded on the NYSE exchange.
Leadership & Workforce
Detailed information about Zimmer Biomet Holdings, Inc.'s leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Zimmer Biomet Holdings, Inc....
Sector & Industry Analysis
In-depth sector dynamics and industry context for Zimmer Biomet Holdings, Inc....
Revenue & Growth Analysis
Zimmer Biomet Holdings, Inc. generates annual revenues of $8 billion , indicating a well-established business with proven market demand.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Zimmer Biomet Holdings, Inc....
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Zimmer Biomet Holdings, Inc....
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Zimmer Biomet Holdings, Inc....
Strategic Market Position
Zimmer Biomet Holdings, Inc. strategically competes in the highly dynamic Orthopedic, Prosthetic & Surgical Appliances & Supplies marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.
Industry Competitive Landscape
Zimmer Biomet Holdings, Inc. competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company demonstrates exceptional operational efficiency through free cash flow generation of $1 billion annually , with year-over-year cash flow growth of -24.0%. This substantial cash generation capability provides significant strategic flexibility for acquisitions, share repurchases, dividend growth, or debt reduction—all while maintaining operational investments necessary to defend market position.
Margin & Pricing Power Analysis
The company maintains a 69.6% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.
Operating margin of 12.2% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. This healthy operating margin shows balanced investment in growth functions while maintaining reasonable profitability.
Asset Utilization Efficiency
Asset turnover ratio of 0.35x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.
Financial Strength & Leverage
Current ratio of 1.69 indicates adequate liquidity to meet short-term obligations with reasonable cushion. This level balances working capital efficiency with financial safety.